105 related articles for article (PubMed ID: 29099284)
1. NF-κB-regulated ubiquitin-editing enzyme A20 paves the way for infection persistency.
Lim MCC; Maubach G; Naumann M
Cell Cycle; 2018; 17(1):3-4. PubMed ID: 29099284
[No Abstract] [Full Text] [Related]
2. Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death.
Lim MCC; Maubach G; Sokolova O; Feige MH; Diezko R; Buchbinder J; Backert S; Schlüter D; Lavrik IN; Naumann M
Cell Death Differ; 2017 Sep; 24(9):1621-1631. PubMed ID: 28574503
[TBL] [Abstract][Full Text] [Related]
3. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
[TBL] [Abstract][Full Text] [Related]
4. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
[TBL] [Abstract][Full Text] [Related]
5. A20 and Cell Death-driven Inflammation.
Priem D; van Loo G; Bertrand MJM
Trends Immunol; 2020 May; 41(5):421-435. PubMed ID: 32241683
[TBL] [Abstract][Full Text] [Related]
6. A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes.
Lappas M
Mol Hum Reprod; 2017 Sep; 23(9):628-645. PubMed ID: 28911210
[TBL] [Abstract][Full Text] [Related]
7. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.
Heyninck K; Beyaert R
Trends Biochem Sci; 2005 Jan; 30(1):1-4. PubMed ID: 15653317
[TBL] [Abstract][Full Text] [Related]
8. A20 restores phorbol ester-induced differentiation of THP-1 cells in the absence of nuclear factor-κB activation.
Osako M; Itsumi M; Yamaguchi H; Takeuchi H; Yamaoka S
J Cell Biochem; 2018 Feb; 119(2):1475-1487. PubMed ID: 28771803
[TBL] [Abstract][Full Text] [Related]
9. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
10. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
[TBL] [Abstract][Full Text] [Related]
11. USP48 and A20 synergistically promote cell survival in Helicobacter pylori infection.
Jantaree P; Chaithongyot S; Sokolova O; Naumann M
Cell Mol Life Sci; 2022 Aug; 79(8):461. PubMed ID: 35913642
[TBL] [Abstract][Full Text] [Related]
12. TNFα induces tolerant production of CXC chemokines in colorectal cancer HCT116 cells via A20 inhibition of ERK signaling.
Zhou X; An D; Liu X; Jiang M; Yuan C; Hu J
Int Immunopharmacol; 2018 Jan; 54():296-302. PubMed ID: 29175508
[TBL] [Abstract][Full Text] [Related]
13. A20 Orchestrates Inflammatory Response in the Oral Mucosa through Restraining NF-κB Activity.
Li Y; Mooney EC; Holden SE; Xia XJ; Cohen DJ; Walsh SW; Ma A; Sahingur SE
J Immunol; 2019 Apr; 202(7):2044-2056. PubMed ID: 30760622
[TBL] [Abstract][Full Text] [Related]
14. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
[TBL] [Abstract][Full Text] [Related]
15. LncRNA UCA1 negatively regulates NF-kB activity in psoriatic keratinocytes through the miR125a-A20 axis.
Ma XL; Wen GD; Yu C; Zhao Z; Gao N; Liu ZY
Kaohsiung J Med Sci; 2021 Mar; 37(3):172-180. PubMed ID: 33554442
[TBL] [Abstract][Full Text] [Related]
16. [ABIN1 is not involved in imatinib upregulating A20 to inhibit the activation of NF-κB pathway in Jurkat T cells].
Chen Q; Wang S; Lin C; Chen S; Zhao X; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):577-580. PubMed ID: 28502291
[TBL] [Abstract][Full Text] [Related]
17. A20 ameliorates inflammatory bowel disease in mice via inhibiting NF-κB and STAT3 activation.
Lee SH; Lee HR; Kwon JY; Jung K; Kim SY; Cho KH; Choi J; Lee HH; Lee BI; Jue DM; Cho ML
Immunol Lett; 2018 Jun; 198():44-51. PubMed ID: 29608924
[TBL] [Abstract][Full Text] [Related]
18. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
19. A20 Restrains Thymic Regulatory T Cell Development.
Fischer JC; Otten V; Kober M; Drees C; Rosenbaum M; Schmickl M; Heidegger S; Beyaert R; van Loo G; Li XC; Peschel C; Schmidt-Supprian M; Haas T; Spoerl S; Poeck H
J Immunol; 2017 Oct; 199(7):2356-2365. PubMed ID: 28842469
[TBL] [Abstract][Full Text] [Related]
20. Intracelluar delivery of A20 protein inhibits TNFα-induced NF-κB activation.
Lee HR; Choi J; Lee SH; Cho ML; Jue DM
Protein Expr Purif; 2018 Mar; 143():14-19. PubMed ID: 28988144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
